Distance Learning

Digital Therapeutics: Emerging Legal, Regulatory, and Ethical Issues - On Demand Recording

Recorded On: 05/22/2019

Time: 90 minutes
Session Format: On Demand Recording
CLE Credit Available:  No

For on-demand webinar recordings, streaming access is available for 12-months from the date of the live webinar.  After 12-months, on-demand webinar recordings are available through the AHLA Health Law Archive.

This session will cover the following:

  • Evolving business models for digital therapeutics companies (and associated legal/regulatory issues)
    • direct-to-consumer
    • Digital providers/ .
    • partnerships/business arrangements (several examples of partnerships/business arrangements between big pharma, big data, payors, and startups)
  • Areas of Medicine Best Positioned for Digital Therapeutics
    • chronic diseases/behavioral
    • high-data/multifactorial diagnoses
    • other
  • Key legal/regulatory issues for digital therapeutics companies (FDA, FTC, privacy and security, fraud and abuse, and reimbursement)
  • Physician/Provider Use of Digital Therapeutics (and associated legal/regulatory issues)
    • standard of care
    • agreements between physicians/providers and digital therapeutics companies

  • Digital therapeutic providers supplying healthcare: contracting, status, obligations, risks. {This may be subsumed in "key legal/regulatory issues}.
  • The Future of Digital Therapeutics
    • emerging legal/regulatory and ethical issues (and some predictions)

Level of Difficulty: Advanced

  • AHLA Member: $99
  • Non-AHLA Member: $149

Content Lead:

  • Life Sciences Practice Group

Ryan Johnson


Fredrikson & Byron, P.A.
Minneapolis, MN

Lucia Savage

Chief Privacy & Regulatory Officer

Omada Health